Nevirapine warning on post-exposure prophylaxis.
Nevirapine should not be used to prevent infection after HIV exposure, except in unusual circumstances, due to the risk of side effects. This warning does not affect its use in HIV treatment, or in prevention of mother to child transmission.
D002487:Centers for Disease Control and Prevention, U.S.; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States
D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine